UI 010
Alternative Names: UI-010Latest Information Update: 08 Sep 2021
At a glance
- Originator Korea United Pharm Inc
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Research Chronic obstructive pulmonary disease
Most Recent Events
- 27 Aug 2021 UI 010 is available for licensing as of 27 Aug 2021. https://www.kup.co.kr/research/innovation_main.htm
- 27 Aug 2021 Early research in Chronic obstructive pulmonary disease in South Korea (Inhalation), prior to August 2021 (Korea United Pharm pipeline, August 2021)
- 27 Aug 2021 Korea United Pharm plans to launch UI 010 for Chronic obstructive pulmonary disease in 2020 (Korea United Pharm pipeline, August 2021)